FDA Seeking Real-Time Clinical Trial Data to Speed Drug Development
- May 01, 2026
- Written by AHLA Legal Staff
The Food and Drug Administration (FDA) is looking to advance real-time clinical trials as part of its broader effort to accelerate drug development timelines and expedite patient access to safe and effective treatments.
ARTICLE TAGS
You must be logged in to access this content.